Yuki Iwayanagi

Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases

Taku Fukuzawa, Zenjiro Sampei, Kenta Haraya et al. · Scientific Reports · 2017 · 104 citations · Full text

Immunohematology, Immunology, Blood Cell +17

Engineered Monoclonal Antibody with Novel Antigen-Sweeping Activity In Vivo

Tomoyuki Igawa, Atsuhiko Maeda, Kenta Haraya et al. · PLoS ONE · 2013 · 97 citations · Full text

Immunocytochemical Technique, Engineering, Immunoengineering +14

HNF4α is a Crucial Modulator of the Cholesterol-Dependent Regulation of NPC1L1

Yuki Iwayanagi, Tappei Takada, Hiroshi Suzuki · Pharmaceutical Research · 2007 · 59 citations

Molecular Physiology, Signal Transduction, Biochemistry +7

Cynomolgus monkey model of interleukin‐31‐induced scratching depicts blockade of human interleukin‐31 receptor A by a humanized monoclonal antibody

Sohei Oyama, Hidetomo Kitamura, Taichi Kuramochi et al. · Experimental Dermatology · 2016 · 54 citations · Full text

LXR Alpha Transactivates Mouse Organic Solute Transporter Alpha and Beta via IR-1 Elements Shared with FXR

Masae Okuwaki, Tappei Takada, Yuki Iwayanagi et al. · Pharmaceutical Research · 2006 · 45 citations

Molecular Pharmacology, Molecular Physiology, Signal Transduction +6